Liu Shu-Ning, Chi Ching-Shiang, Lee Hsiu-Fen, Tsai Chi-Ren, Yang Yao-Lun, Wu Pei-Yu
Division of Pediatric Neurology, Children's Medical Center, Taichung Veterans General Hospital, 1650, Taiwan Boulevard Sec. 4, Taichung, 407, Taiwan.
Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, 145, Xingda Rd., Taichung, 402, Taiwan.
Orphanet J Rare Dis. 2025 Jul 25;20(1):376. doi: 10.1186/s13023-025-03908-9.
The focus of this study was a comparison of the phenotypical and genotypical differences in PURA syndrome among Asian and non-Asian patients. A retrospective cohort study was performed in a single medical center from January 2014 to May 2025 on patients carrying causative genes for PURA syndrome. A systematic search in PubMed, MEDLINE, Web of Science, and Embase covering the period from January 2014 to May 2025 was conducted. Individuals with PURA syndrome were collected and categorized into Asian and non-Asian groups for analysis. Clinical characteristics, imaging findings, and developmental outcomes were compared between the two groups using Chi-squared or Fisher's exact tests, with a p < 0.05 considered statistically significant.
Of 200 individuals enrolled, 44 were Asian and 156 were non-Asian. 80% or more of individuals with PURA syndrome in both groups shared common clinical features of hypotonia and feeding difficulties during the neonatal period. In terms of neurologic symptoms, there were significantly higher rates of pathological startle response (p < 0.01), and lower rates of epilepsy (p < 0.01) and movement disorders (p = 0.035) among Asian populations. For extra-neurologic symptoms, Asian populations showed a higher incidence of cardiac (p = 0.013) and urogenital abnormalities (p < 0.01), with statistical significance. A single patient in the cohort study exhibited second-degree atrioventricular block, which required pacemaker placement. Highly heterogeneous variants were identified with 106 causative variants in 200 individuals, including a novel causative variant, c.42_57del (p.Leu15fs), from our cohort. All individuals with PURA syndrome displayed evident psychomotor impairment during follow-up.
PURA syndrome exhibits high phenotypic and genotypic heterogeneity. Increased pathological startle response, reduced epilepsy and movement disorders, and higher rates of cardiac and urogenital abnormalities were observed in the Asian group. Cardiac conduction disorder may prove fatal without timely intervention.
本研究的重点是比较亚洲和非亚洲PURA综合征患者的表型和基因型差异。2014年1月至2025年5月在单一医疗中心对携带PURA综合征致病基因的患者进行了一项回顾性队列研究。对2014年1月至2025年5月期间的PubMed、MEDLINE、科学网和Embase进行了系统检索。收集患有PURA综合征的个体并将其分为亚洲组和非亚洲组进行分析。使用卡方检验或Fisher精确检验比较两组之间的临床特征、影像学表现和发育结局,p < 0.05被认为具有统计学意义。
在纳入的200名个体中,44名是亚洲人,156名是非亚洲人。两组中80%或更多的PURA综合征个体在新生儿期具有肌张力低下和喂养困难的共同临床特征。在神经症状方面,亚洲人群中病理性惊吓反应的发生率显著更高(p < 0.01),癫痫(p < 0.01)和运动障碍(p = 0.035)的发生率更低。对于非神经症状,亚洲人群中心脏(p = 0.013)和泌尿生殖系统异常(p < 0.01)的发生率更高,具有统计学意义。队列研究中有一名患者表现为二度房室传导阻滞,需要植入起搏器。在200名个体中鉴定出106个致病变体,具有高度异质性,包括来自我们队列的一个新的致病变体c.42_57del(p.Leu15fs)。所有患有PURA综合征的个体在随访期间均表现出明显的精神运动障碍。
PURA综合征表现出高度的表型和基因型异质性。在亚洲组中观察到病理性惊吓反应增加、癫痫和运动障碍减少以及心脏和泌尿生殖系统异常的发生率更高。心脏传导障碍若不及时干预可能会致命。